A lipopolysaccharide mouse model mirrors neuroinflammatory transcriptional signatures of human Alzheimer's disease, and the Glucagon‐Like Peptide‐1 receptor agonist semaglutide attenuates neuroinflammation in this model.

Authors :: Ludwig, Mette Q
Belmont‐Rausch, Dylan M
Bentsen, Marie Aare
Secher, Anna
Hansen, Stine A Normann
Egerod, Kristoffer L
Hansen, Charlotte Thim
Dalgaard, Kevin D
Merkestein, Myrte
Holst, Dorte
Pyke, Charles
Wichern, Franziska
Polex‐Wolf, Joseph
Pers, Tune H
Knudsen, Lotte Bjerre
Source :: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2022 Supplement 10, Vol. 18 Issue 10, p1-2, 2p
Publication Year :: 2022

Language :: English
ISSN :: 15525260
Volume :: 18
Issue :: 10
Database :: Complementary Index
Journal :: Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Publication Type :: Academic Journal
Accession number :: 160884342
Full Text :: https://doi.org/10.1002/alz.063862

Full Text Access

Tools